National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Capsaicin 8% w/w patch (Qutenza®) for peripheral neuropathic pain in non-diabetic adults either alone or in combination with other medicinal products for pain.

Rapid Review

Commenced Completed Outcome
15/06/2012 28/06/2012 Full Pharmacoeconomic Evaluation Recommended

The company has not submitted a HTA dossier to the NCPE therefore the cost effectiveness of the technology could not be proven.